Trump authorizes military force against Latin American drug cartels, raising legal and diplomatic concerns.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.
Trump authorizes military force against Latin American drug cartels, raising legal and diplomatic concerns.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Expedia Group reports strong Q2 2025 results, raises full-year guidance amid international gains, sending shares higher.